Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Nicholas Pavlidis

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Antineoplastic Combined Chemotherapy Protocols

Disorders

Concepts & Ideas

Chemicals & Drugs

Geographic Areas

Greece

Physiology

Disease Progression

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Hyphantis Thomas; Tomenson Barbara; Paika Vassiliki; Almyroudi Augoustina; Pappa Chrisavgi; Tsifetaki Niki; Voulgari Paraskevi V; Drosos Alexandros A; Pavlidis Nicholas; Creed Francis
Somatization is associated with physical health-related quality of life independent of anxiety and depression in cancer, glaucoma and rheumatological disorders.
Pavlidis Nicholas
Evidence-based medicine: development and implementation of guidelines in oncology.
Pentheroudakis George; Kalogeras Konstantine T; Wirtz Ralph M; Grimani Irene; Zografos George; Gogas Helen; Stropp Udo; Pectasides Dimitrios; Skarlos Dimosthenis; Hennig Guido; Samantas Epaminondas; Bafaloukos Dimitrios; Papakostas Pavlos; Kalofonos Haralabos P; Pavlidis Nicholas; Fountzilas George
Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Nicholas Pavlidis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Hyphantis Thomas; Tomenson Barbara; Paika Vassiliki; Almyroudi Augoustina; Pappa Chrisavgi; Tsifetaki Niki; Voulgari Paraskevi V; Drosos Alexandros A; Pavlidis Nicholas; Creed Francis
Somatization is associated with physical health-related quality of life independent of anxiety and depression in cancer, glaucoma and rheumatological disorders.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2009;18(8):1029-42.
2009: Pavlidis Nicholas
Evidence-based medicine: development and implementation of guidelines in oncology.
European journal of cancer (Oxford, England : 1990) 2009;45 Suppl 1():468-70.
2009: Pentheroudakis George; Kalogeras Konstantine T; Wirtz Ralph M; Grimani Irene; Zografos George; Gogas Helen; Stropp Udo; Pectasides Dimitrios; Skarlos Dimosthenis; Hennig Guido; Samantas Epaminondas; Bafaloukos Dimitrios; Papakostas Pavlos; Kalofonos Haralabos P; Pavlidis Nicholas; Fountzilas George
Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Breast cancer research and treatment 2009;116(1):131-43.
2009: Pavlidis Nicholas; Pentheroudakis George; Plataniotis George
Cervical lymph node metastases of squamous cell carcinoma from an unknown primary site: a favourable prognosis subset of patients with CUP.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2009;11(6):340-8.
2009: Pavlidis N; Hansen H; Stahel R
ESMO clinical recommendations: using the easier and faster approach to oncology guidelines.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20 Suppl 4():7-9.
2009: Pentheroudakis G; Pavlidis N; Castiglione M;
Cancer, fertility and pregnancy: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20 Suppl 4():178-81.
2009: Briasoulis E; Pavlidis N; Felip E;
Cancers of unknown primary site: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20 Suppl 4():154-5.
2009: Voulgaris E; Pentheroudakis G; Vassou A; Pavlidis N
Disseminated intravascular coagulation (DIC) and non-small cell lung cancer (NSCLC): report of a case and review of the literature.
Lung cancer (Amsterdam, Netherlands) 2009;64(2):247-9.
2009: Pentheroudakis George; Greco F A; Pavlidis Nicholas
Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: a systematic literature review.
Cancer treatment reviews 2009;35(3):221-7.
2009: Mauri Davide; Valachis Antonis; Polyzos Nikolaos P; Cortinovis Ivan; Karampoiki Vassiliki; Loukidou Evridiki; Alevizaki Paraskevi; Kamposioras Konstantinos; Kouris Georgios; Alexandropoulou Parthenopi; Tsali Lamprini; Panou Charalampos; Stamatelopoulos Athanasios; Lakiotis Velisarios; Spiliopoulou Anastasia; Terzoudi Aikaterini; Ioakimidou Aliki; Karathanasi Ioanna; Bristianou Magdalini; Casazza Giovanni; Pavlidis Nicholas
Screening practice and misplaced priorities.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2009;11(4):228-36.
2009: Pavlidis Nicholas; Fizazi Karim
Carcinoma of unknown primary (CUP).
Critical reviews in oncology/hematology 2009;69(3):271-8.
2009: Golfinopoulos Vassilis; Pentheroudakis George; Kamakari Smaragda; Metaxa-Mariatou Vasiliki; Pavlidis Nicholas
Donor-derived breast cancer in a bone marrow transplantation recipient.
Breast cancer research and treatment 2009;113(2):211-3.
2009: Pentheroudakis George; Angouridakis Nikolaos; Wirtz Ralph; Nikolaou Angelos; Kalogeras Konstantine T; Pavlidis Nicholas; Fountzilas George
Transcriptional activity of human epidermal growth factor receptor family and angiogenesis effectors in locoregionally recurrent head and neck squamous cell carcinoma and correlation with patient outcome.
Journal of oncology 2009;2009():854127.
2008: Pentheroudakis G; Stahel R; Hansen H; Pavlidis N
Heterogeneity in cancer guidelines: should we eradicate or tolerate?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(12):2067-78.
2008: Lazaridis George; Pentheroudakis George; Fountzilas George; Pavlidis Nicholas
Liver metastases from cancer of unknown primary (CUPL): a retrospective analysis of presentation, management and prognosis in 49 patients and systematic review of the literature.
Cancer treatment reviews 2008;34(8):693-700.
2008: Siafaka Vassiliki; Hyphantis Thomas N; Alamanos Ioannis; Fountzilas Georgios; Skarlos Demosthenis; Pectasides Demetrios; Mavreas Venetsanos; Pavlidis Nicholas
Personality factors associated with psychological distress in testicular cancer survivors.
Journal of personality assessment 2008;90(4):348-55.
2008: Briasoulis E; Fountzilas G; Bamias A; Dimopoulos M A; Xiros N; Aravantinos G; Samantas E; Kalofonos H; Makatsoris T; Mylonakis N; Papakostas P; Skarlos D; Varthalitis I; Pavlidis N
Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study.
Cancer chemotherapy and pharmacology 2008;62(2):277-84.
2008: Pentheroudakis George; Fountzilas George; Kalofonos Haralabos P; Golfinopoulos Vassilios; Aravantinos Gerasimos; Bafaloukos Dimitrios; Papakostas Pavlos; Pectasides Dimitrios; Christodoulou Christos; Syrigos Konstantinos; Economopoulos Theofanis; Pavlidis Nicholas;
Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
Critical reviews in oncology/hematology 2008;66(3):237-47.
2008: Briasoulis E; Pavlidis N; Felip E;
Cancers of unknown primary site: ESMO clinical recommendation for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19 Suppl 2():ii106-7.
2008: Briasoulis Evangelos; Kamposioras Konstantinos; Tzovaras Vasilis; Pafitanis George; Kostoula Angeliki; Mavridis Anestis; Pavlidis Nicholas
CENP-B specific anti-centromere autoantibodies heralding small-cell lung cancer. A case study and review of the literature.
Lung cancer (Amsterdam, Netherlands) 2008;60(2):302-6.
2008: Papaxoinis G; Fountzilas G; Rontogianni D; Dimopoulos M A; Pavlidis N; Tsatalas C; Pectasides D; Xiros N; Economopoulos T
Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(4):780-6.
2008: Kamposioras Konstantinos; Pentheroudakis George; Malamou-Mitsi Vassiliki; Pappa Lina; Bafa Maria; Pavlidis Nicholas
Can circulated lung cancer cells pass to the urine without apparent urine tract metastases? A single centre series.
Lung cancer (Amsterdam, Netherlands) 2008;60(1):141-5.
2008: Lazaridis George; Pentheroudakis George; Pavlidis Nicholas
Integrating trastuzumab in the neoadjuvant treatment of primary breast cancer: accumulating evidence of efficacy, synergy and safety.
Critical reviews in oncology/hematology 2008;66(1):31-41.
2008: Pentheroudakis George; Briasoulis Evangelos; Kalofonos Haralambos P; Fountzilas Georgios; Economopoulos Theofanis; Samelis George; Koutras Aris; Karina Maria; Xiros Nikolaos; Samantas Epameinondas; Bamias Aristotelis; Pavlidis Nikolaos;
Docetaxel and carboplatin combination chemotherapy as outpatient palliative therapy in carcinoma of unknown primary: a multicentre Hellenic Cooperative Oncology Group phase II study.
Acta oncologica (Stockholm, Sweden) 2008;47(6):1148-55.
2007: Kosmidis P; Fountzilas G; Baka S; Samantas E; Dimopoulos A M; Gogas H; Skarlos D; Papacostas P; Boukovinas J; Bakogiannis Ch; Pantelakos P; Athanasiou H; Misailidou D; Tsekeris P; Pavlidis N
Combination chemotherapy with paclitaxel and gemcitabine followed by concurrent chemoradiotherapy in non-operable localized non-small cell lung cancer. A hellenic cooperative oncology group (HeCOG) phase II study.
Anticancer research 2007;27(6C):4391-5.
2007: Joerger Markus; Huitema Alwin D R; Richel Dick J; Dittrich Christian; Pavlidis Nikolas; Briasoulis Evangelos; Vermorken Jan B; Strocchi Elena; Martoni Andrea; Sorio Roberto; Sleeboom Henk P; Izquierdo Miguel A; Jodrell Duncan I; Calvert Hilary; Boddy Alan V; Hollema Harry; Féty Regine; Van der Vijgh Wjf J F; Hempel Georg; Chatelut Etienne; Karlsson Mats; Wilkins Justin; Tranchand Brigitte; Schrijvers Ad H G J; Twelves Christian; Beijnen Jos H; Schellens Jan H M
Population pharmacokinetics and pharmacodynamics of paclitaxel and carboplatin in ovarian cancer patients: a study by the European organization for research and treatment of cancer-pharmacology and molecular mechanisms group and new drug development group.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(21):6410-8.
2007: Pentheroudakis George; Pavlidis Nicholas
Late toxicity in survivors from adolescent cancers.
Cancer treatment reviews 2007;33(7):656-63.
2007: Golfinopoulos Vassilis; Salanti Georgia; Pavlidis Nicholas; Ioannidis John P A
Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis.
The lancet oncology 2007;8(10):898-911.
2007: Pentheroudakis G; Pappas P; Golfinopoulos V; Fountzilas G; Nikolaidou M; Boumba V A; Vougiouklakis T; Nikiforidis L; Tzamakou E; Siarabi O; Marselos M; Pavlidis N
Weekday on-weekend off oral capecitabine: a phase I study of a continuous schedule better simulating protracted fluoropyrimidine therapy.
Cancer chemotherapy and pharmacology 2007;60(5):733-9.
2007: Pentheroudakis George; Golfinopoulos Vassilios; Pavlidis Nicholas
Switching benchmarks in cancer of unknown primary: from autopsy to microarray.
European journal of cancer (Oxford, England : 1990) 2007;43(14):2026-36.
2007: Pavlidis N; Vermorken J B; Stahel R; Bernier J; Cervantes A; Audisio R; Pentheroudakis G; Costa A
Oncology for medical students: a European School of Oncology contribution to undergraduate cancer education.
Cancer treatment reviews 2007;33(5):419-26.
2007: Kostadima L; Pentheroudakis G; Pavlidis N
The missing kiss of life: transcriptional activity of the metastasis suppressor gene KiSS1 in early breast cancer.
Anticancer research 2007;27(4B):2499-504.
2007: Pavlidis N
Towards a convenient way to practice medical oncology.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18 Suppl 2():ii3-4.
2007: Pentheroudakis George; Briasoulis Evangelos; Pavlidis Nicholas
Cancer of unknown primary site: missing primary or missing biology?
The oncologist 2007;12(4):418-25.
2007: Tzioras Spyridon; Pavlidis Nicholas; Paraskevaidis Evangelos; Ioannidis John P A
Effects of different chemotherapy regimens on survival for advanced cervical cancer: systematic review and meta-analysis.
Cancer treatment reviews 2007;33(1):24-38.
2007: Pavlidis Nicholas
Forty years experience of treating cancer of unknown primary.
Acta oncologica (Stockholm, Sweden) 2007;46(5):592-601.
2007: Dova Leukothea; Pentheroudakis George; Georgiou Ioannis; Malamou-Mitsi Vassiliki; Vartholomatos George; Fountzilas George; Kolaitis Nikolaos; Kitsiou Evangelia; Pavlidis Nicholas
Global profiling of EGFR gene mutation, amplification, regulation and tissue protein expression in unknown primary carcinomas: to target or not to target?
Clinical & experimental metastasis 2007;24(2):79-86.
2006: Pentheroudakis George; Pavlidis Nicholas
Perspectives for targeted therapies in cancer of unknown primary site.
Cancer treatment reviews 2006;32(8):637-44.
2006: Mauri Davide; Kamposioras Konstantinos; Proiskos Anastasios; Xilomenos Apostolos; Peponi Christina; Dambrosio Mario; Zacharias Georgios; Koukourakis Georgios; Pentheroudakis George; Pavlidis Nicholas
Old habits die hard: chest radiography for screening purposes in primary care.
The American journal of managed care 2006;12(11):650-6.
2006: Briasoulis Evangelos; Karavasilis Vasilis; Tzamakou Eleftheria; Piperidou Christina; Soulti Kali; Pavlidis Nicholas
Feasibility study and pharmacokinetics of low-dose paclitaxel in cancer patients with severe hepatic dysfunction.
Anti-cancer drugs 2006;17(10):1219-22.
2006: Kostadima Lida; Pentheroudakis George; Fountzilas George; Dimopoulos Meletios; Pectasides Dimitrios; Gogas Helen; Stropp Udo; Christodoulou Christos; Samantas Epameinondas; Wirtz Ralph; Hennig Guido; Bafaloukos Dimitrios; Arapantoni P; Kalofonos Haralambos; Papakostas Pavlos; Economopoulos Theofanis; Bamias Aristotelis; Pavlidis Nicholas
Survivin and glycodelin transcriptional activity in node-positive early breast cancer: mRNA expression of two key regulators of cell survival.
Breast cancer research and treatment 2006;100(2):161-7.
2006: Papaxoinis George; Papageorgiou Sotirios; Rontogianni Dimitra; Kaloutsi Vassiliki; Fountzilas George; Pavlidis Nikolaos; Dimopoulos Meletios; Tsatalas Constantinos; Xiros Nikolaos; Economopoulos Theofanis
Primary gastrointestinal non-Hodgkin's lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG).
Leukemia & lymphoma 2006;47(10):2140-6.
2006: Fountzilas G; Papakostas P; Dafni U; Makatsoris T; Karina M; Kalogera-Fountzila A; Maniadakis N; Aravantinos G; Syrigos K; Bamias A; Christodoulou C; Economopoulos T; Kalofonos Hp; Nikolaou A; Angouridakis N; Stathopoulos G; Bafaloukos D; Pavlidis N; Daniilidis J
Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(10):1560-7.
2006: Mauri Davide; Pavlidis Nicholas; Polyzos Nikolaos P; Ioannidis John P A
Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis.
Journal of the National Cancer Institute 2006;98(18):1285-91.
2006: Pectasides Dimitrios; Fountzilas George; Aravantinos Gerassimos; Kalofonos Charalambos; Efstathiou Helen; Farmakis Dimitrios; Skarlos Dimosthenes; Pavlidis Nikolaos; Economopoulos Theofanis; Dimopoulos Meletios A
Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
Gynecologic oncology 2006;102(2):285-91.
2006: Pentheroudakis George; Neanidis Konstantinos; Kostadima Lida; Fountzilas George; Pavlidis Nicholas
Elderly patients with squamous lung carcinoma: faring better or worse?
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2006;14(8):867-70.
2006: Mauri D; Pentheroudakis G; Bafaloukos D; Pectasides D; Samantas E; Efstathiou E; Kalofonos H P; Syrigos K; Klouvas G; Papakostas P; Kosmidis P; Fountzilas G; Pavlidis N;
Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome data.
Anticancer research 2006;26(4B):3175-81.
2006: Pentheroudakis George; Mauri Davide; Kostadima Lida; Golfinopoulos Vassilis; Alexiou George; Karakatsanis Anestis; Pavlidis Nicholas
"Juvenile" oncology--a missing subspecialty. The experience of a reference cancer centre.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2006;8(6):444-9.
2006: Zagorianakou N; Stefanou D; Makrydimas G; Zagorianakou P; Briasoulis E; Karavasilis V; Pavlidis N; Agnantis N J
Clinicopathological study of metallothionein immunohistochemical expression, in benign, borderline and malignant ovarian epithelial tumors.
Histology and histopathology 2006;21(4):341-7.
2006: Polyzos Nikolaos P; Pavlidis Nicholas; Paraskevaidis Evangelos; Ioannidis John P A
Randomized evidence on chemotherapy and hormonal therapy regimens for advanced endometrial cancer: an overview of survival data.
European journal of cancer (Oxford, England : 1990) 2006;42(3):319-26.
2006: Golfinopoulos Vassilis; Pentheroudakis George; Pavlidis Nicholas
Treatment of colorectal cancer in the elderly: a review of the literature.
Cancer treatment reviews 2006;32(1):1-8.
2006: Karavasilis V; Malamou-Mitsi V; Briasoulis E; Tsanou E; Kitsou E; Pavlidis N
Clinicopathologic study of vascular endothelial growth factor, thrombospondin-1, and microvessel density assessed by CD34 in patients with stage III ovarian carcinoma.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16 Suppl 1():241-6.
2006: Pentheroudakis George; Pavlidis Nicholas
Cancer and pregnancy: poena magna, not anymore.
European journal of cancer (Oxford, England : 1990) 2006;42(2):126-40.
2006: Pentheroudakis G; Razis E; Athanassiadis A; Pavlidis N; Fountzilas G
Paclitaxel-carboplatin combination chemotherapy in advanced breast cancer: accumulating evidence for synergy, efficacy, and safety.
Medical oncology (Northwood, London, England) 2006;23(2):147-60.
2006: Mauri Davide; Pentheroudakis George; Milousis Athanasios; Xilomenos Apostolos; Panagoulopoulou Evaggelia; Bristianou Magdalini; Zacharias Georgios; Christidis Dimitrios; Mustou Evaggelia Aikaterini; Gkinosati Athanasia; Pavlidis Nicholas;
Colorectal cancer screening awareness in European primary care.
Cancer detection and prevention 2006;30(1):75-82.
2005: Karavasilis Vasilis; Malamou-Mitsi Vasiliki; Briasoulis Evangelos; Tsanou Elena; Kitsou Evangelia; Kalofonos Haralambos; Fountzilas George; Fotsis Theodore; Pavlidis Nicholas
Matrix metalloproteinases in carcinoma of unknown primary.
Cancer 2005;104(10):2282-7.
2005: Briasoulis E; Samantas E; Kalofonos H; Skarlos D; Makatsoris T; Christodoulou C; Fountzilas G; Bamias A; Dimopoulos M A; Kosmidis P; Pavlidis N
Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancer.
Cancer chemotherapy and pharmacology 2005;56(5):521-8.
2005: Economopoulos Theofanis; Papageorgiou Sotirios; Rontogianni Dimitra; Kaloutsi Vassiliki; Fountzilas George; Tsatalas Constantinos; Pavlidis Nikolaos; Pectasides Dimitrios; Papageorgiou Efstathios; Dimopoulos Meletios;
Multifocal extranodal non-hodgkin lymphoma: a clinicopathologic study of 37 cases in Greece, a Hellenic Cooperative Oncology Group study.
The oncologist 2005;10(9):734-8.
2005: Pavlidis Nicholas; Pentheroudakis George
The pregnant mother with breast cancer: diagnostic and therapeutic management.
Cancer treatment reviews 2005;31(6):439-47.
2005: Pappas Periklis; Karavasilis Vasilis; Briasoulis Evangelos; Pavlidis Nicholas; Marselos Marios
Pharmacokinetics of imatinib mesylate in end stage renal disease. A case study.
Cancer chemotherapy and pharmacology 2005;56(4):358-60.
2005: Mauri Davide; Pentheroudakis George; Tolis Christos; Chojnacka Marzanna; Pavlidis Nicholas
Inflammatory prostate cancer: an underestimated paraneoplastic clinical manifestation.
Urologic oncology 2005;23(5):318-22.
2005: Pectasides Dimitrios; Aravantinos Gerasimos; Fountzilas George; Kalofonos Charalampos; Efstathiou Eleni; Karina Maria; Pavlidis Nicolaos; Farmakis Dimitrios; Economopoulos Theofanis; Dimopoulos Meletios A
Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literature.
Anticancer research 2005;25(5):3553-8.
2005: Papageorgiou Efstathios S; Tsirigotis Panagiotis; Dimopoulos Meletios; Pavlidis Nikolaos; Fountzilas George; Papageorgiou Sotirios; Economopoulos Theofanis;
Combination chemotherapy with gemcitabine and vinorelbine in the treatment of relapsed or refractory diffuse large B-cell lymphoma: a phase-II trial by the Hellenic Cooperative Oncology Group.
European journal of haematology 2005;75(2):124-9.
2005: Skarlos Dimosthenis V; Kalofonos Haralabos P; Fountzilas George; Dimopoulos Meletios A; Pavlidis Nicholas; Razis Evangelia; Economopoulos Theofanis; Pectasides Dimitrios; Gogas Helen; Kosmidis Paris; Bafaloukos Dimitrios; Klouvas George; Kyratzis George; Aravantinos Gerasimos
Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II study.
Anticancer research 2005;25(4):3103-8.
2005: Fountzilas George; Pectasides Dimitrios; Kalogera-Fountzila Anna; Skarlos Dimosthenis; Kalofonos Haralambos P; Papadimitriou Christos; Bafaloukos Dimitrios; Lambropoulos Stefanos; Papadopoulos Savvas; Kourea Helen; Markopoulos Christos; Linardou Helen; Mavroudis Dimitrios; Briasoulis Evangelos; Pavlidis Nicholaos; Razis Evangelia; Kosmidis Paraskevas; Gogas Helen
Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology Group.
Breast cancer research and treatment 2005;92(1):1-9.
2005: Aravantinos G; Fountzilas G; Kosmidis P; Dimopoulos M A; Stathopoulos G P; Pavlidis N; Bafaloukos D; Papadimitriou C; Karpathios S; Georgoulias V; Papakostas P; Kalofonos H P; Grimani E; Skarlos D V;
Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer: long-term efficacy results: a Hellenic Cooperative Oncology Group (HeCOG) study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(7):1116-22.
2005: Briasoulis Evangelos; Rontogianni Demetra; Karavasilis Vasilis; Pavlidis Nicholas
Oxaliplatin (Eloxatin) plus irinotecan combination chemotherapy found effective in refractory metastatic insular thyroid carcinoma.
Thyroid : official journal of the American Thyroid Association 2005;15(6):614-7.
2005: Pentheroudakis George; Pavlidis Nicholas
Management of leptomeningeal malignancy.
Expert opinion on pharmacotherapy 2005;6(7):1115-25.
2005: Polyzoidis Konstantinos S; Miliaras George; Pavlidis Nicholas
Brain metastasis of unknown primary: a diagnostic and therapeutic dilemma.
Cancer treatment reviews 2005;31(4):247-55.
2005: Pavlidis Nicholas; Fizazi Karim
Cancer of unknown primary (CUP).
Critical reviews in oncology/hematology 2005;54(3):243-50.
2005: Pentheroudakis G; Briasoulis E; Karavassilis V; Mauri D; Tzamakou E; Rammou D; Pavlidis N
Phase I trial of intravenous cisplatin-topotecan chemotherapy for three consecutive days in patients with advanced solid tumors: parallel topotecan escalation in two fixed platinum dosing schemes.
Chemotherapy 2005;51(2-3):154-61.
2005: Karavasilis Vasilis; Malamou-Mitsi Vasiliki; Briasoulis Evangelos; Tsanou Elena; Kitsou Evangelia; Kalofonos Haralambos; Fountzilas George; Fotsis Theodore; Pavlidis Nicholas
Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1.
BMC cancer 2005;5():25.
2005: Mauri Davide; Pavlidis Nicholas; Ioannidis John P A
Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis.
Journal of the National Cancer Institute 2005;97(3):188-94.
2005: Pentheroudakis G; Pavlidis N
Juvenile cancer: improving care for adolescents and young adults within the frame of medical oncology.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(2):181-8.
2005: Bamias Aristotle; Basdanis George; Xanthakis Ioannis; Pavlidis Nicholas; Fountzilas George
Prognostic factors in patients with colorectal cancer receiving adjuvant chemotherapy or chemoradiotherapy: a pooled analysis of two randomized studies.
International journal of gastrointestinal cancer 2005;36(1):29-38.
2005: Fountzilas George; Tolis Christos; Kalogera-Fountzila Anna; Misailidou Despina; Tsekeris Periklis; Karina Maria; Nikolaou Angelos; Samantas Epaminondas; Makatsoris Thomas; Athanassiou Eleni; Skarlos Dimosthenis; Bamias Aristotelis; Zamboglou Nikolas; Economopoulos Theofanis; Karanastassi Sophia; Pavlidis Nicholas; Daniilidis John
Paclitaxel, cisplatin, leucovorin, and continuous infusion fluorouracil followed by concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the head and neck: a Hellenic Cooperative Oncology Group Phase II Study.
Medical oncology (Northwood, London, England) 2005;22(3):269-79.
2005: Briasoulis E; Tolis C; Bergh J; Pavlidis N;
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cancers of unknown primary site (CUP).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 1():i75-6.
2005: Economopoulos T; Papageorgiou S; Dimopoulos M A; Pavlidis N; Tsatalas C; Symeonidis A; Foudoulakis A; Pectasides D; Rontogianni D; Rizos E; Chalkia P; Anagnostopoulos A; Melachrinou M; Papageorgiou E; Fountzilas G
Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases.
Acta haematologica 2005;113(2):97-103.
2005: Pentheroudakis George; Briasoulis Evangelos; Karavassilis Vassilis; Fountzilas George; Xeros Nikolaos; Samelis George; Samantas Epaminondas; Pavlidis Nicholas
Chemotherapy for patients with two favourable subsets of unknown primary carcinoma: active, but how effective?
Acta oncologica (Stockholm, Sweden) 2005;44(2):155-60.
2004: Tsanou E; Ioachim E; Briasoulis E; Charchanti A; Damala K; Karavasilis V; Pavlidis N; Agnantis N J
Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components.
Journal of experimental & clinical cancer research : CR 2004;23(4):641-50.
2004: Bamias Aristotle; Syrigos Konstantinos; Fountzilas George; Tzamakou Eleftheria; Soulti Kali; Karavasilis Vasilios; Alamanos Yiannis; Christodoulou Christos; Pavlidis Nicholas
Intensified bimonthly cisplatin with bolus 5-fluorouracil, continuous 5-fluorouracil and high-dose leucovorin (LV5FU2) in Patients with advanced gastrointestinal carcinomas: a phase I dose-finding and pharmacokinetic study.
American journal of clinical oncology 2004;27(5):465-71.
2004: Pentheroudakis George; Malamou-Mitsi Vassiliki; Briasoulis Evangelos; Damala Konstantina; Vassou Amalia; Vartholomatos George; Kolaitis Nikos; Pavlidis Nikolas
The neutrophil, not the tumor: serum CA 15-3 elevation as a result of granulocyte--colony-stimulating factor-induced neutrophil MU1C overexpression and neutrophilia in patients with breast carcinoma receiving adjuvant chemotherapy.
Cancer 2004;101(8):1767-75.
2004: Briasoulis E; Pentheroudakis G; Karavasilis V; Tzamakou E; Rammou D; Pavlidis N
Weekly paclitaxel combined with pegylated liposomal doxorubicin (CaelyxTM) given every 4 weeks: dose-finding and pharmacokinetic study in patients with advanced solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(10):1566-73.
2004: Briasoulis Evangelos; Karavasilis Vasilis; Kostadima Lida; Ignatiadis Michael; Fountzilas George; Pavlidis Nicholas
Metastatic breast carcinoma confined to bone: portrait of a clinical entity.
Cancer 2004;101(7):1524-8.
2004: Mauri D; Pazarlis P; Mauri J; Altinoz H; Rivas Flores F J; Karentzou I; Proiskos A; Lakiotis V; Maragkaki A; Terzoudi E; Dambrosio E M; Spiliopoulou A; Varsami A; Alexandropoulou P; Tolis C; Pavlidis N; Vittoraki A
SESy-Europe: a multi-language database dedicated to cancer screening monitoring.
Journal of experimental & clinical cancer research : CR 2004;23(3):441-5.
2004: Briasoulis E; Pentheroudakis G; Timotheadou H; Rammou D; Pavlidis N; Fountzilas G
Biweekly administration of 24-h infusion of irinotecan followed by a 1-h infusion of docetaxel: a phase I study.
Anti-cancer drugs 2004;15(8):747-52.
2004: Karpozilos A; Pavlidis N
The treatment of cancer in Greek antiquity.
European journal of cancer (Oxford, England : 1990) 2004;40(14):2033-40.
2004: Pentheroudakis G; Kostadima L; Fountzilas G; Kalogera-Fountzila A; Klouvas G; Kalofonos C; Pavlidis N
Cavitating squamous cell lung carcinoma-distinct entity or not? Analysis of radiologic, histologic, and clinical features.
Lung cancer (Amsterdam, Netherlands) 2004;45(3):349-55.
2004: Tsanou E; Ioachim E; Briasoulis E; Damala K; Charchanti A; Karavasilis V; Pavlidis N; Agnantis N J
Immunohistochemical expression of superoxide dismutase (MnSOD) anti-oxidant enzyme in invasive breast carcinoma.
Histology and histopathology 2004;19(3):807-13.
2004: Briasoulis Evangelos; Karavasilis Vasilis; Tzamakou Eleftheria; Rammou Dimitra; Soulti Kali; Piperidou Christina; Pavlidis Nicholas
Interaction pharmacokinetics of pegylated liposomal doxorubicin (Caelyx) on coadministration with paclitaxel or docetaxel.
Cancer chemotherapy and pharmacology 2004;53(5):452-7.
2004: Fountzilas George; Stathopoulos G; Kouvatseas G; Polychronis A; Klouvas G; Samantas E; Zamboglou N; Kyriakou K; Adamou A; Pectasidis D; Ekonomopoulos Th; Kalofonos H P; Bafaloukos D; Georgoulias V; Razis E; Koukouras D; Zombolas V; Kosmidis P; Skarlos D; Pavlidis N;
Adjuvant cytotoxic and endocrine therapy in pre- and postmenopausal patients with breast cancer and one to nine infiltrated nodes: five-year results of the Hellenic Cooperative Oncology Group randomized HE 10/92 study.
American journal of clinical oncology 2004;27(1):57-67.
2004: Pavlidis N
The diagnostic and therapeutic management of leptomeningeal carcinomatosis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15 Suppl 4():iv285-91.
2003: Briasoulis E; Pavlidis N; Terret C; Bauer J; Fiedler W; Schöffski P; Raoul J L; Hess D; Selvais R; Lacombe D; Bachmann P; Fumoleau P
Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer. A phase II trial of the EORTC-new drug development group.
European journal of cancer (Oxford, England : 1990) 2003;39(16):2334-40.
2003: Ioannidis J P A; Polycarpou A; Ntais C; Pavlidis N
Randomised trials comparing chemotherapy regimens for advanced non-small cell lung cancer: biases and evolution over time.
European journal of cancer (Oxford, England : 1990) 2003;39(16):2278-87.
2003: Pavlidis N; Briasoulis E; Hainsworth J; Greco F A
Diagnostic and therapeutic management of cancer of an unknown primary.
European journal of cancer (Oxford, England : 1990) 2003;39(14):1990-2005.
2003: Aravantinos G; Bafaloukos D; Fountzilas G; Christodoulou C; Papadimitriou C; Pavlidis N; Kalofonos H P; Gogas H; Kosmidis P; Dimopoulos M A
Phase II study of docetaxel-vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(7):1094-9.
2003: Skarlos Dimosthenis-Vasilios; Dimopoulos Athanassios-Meletios; Kosmidis Paraskevas; Papakostas Pavlos; Pavlidis Nicholas; Bacoyiannis Charalambos; Kiamouris Christos; Klouvas Georgios; Gogas Helen; Fountzilas George; Samantas Epaminondas;
Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group.
Lung cancer (Amsterdam, Netherlands) 2003;41(1):107-11.
2003: Karavasilis Vasilis; Briasoulis Evangelos; Siarabi Olga; Pavlidis Nicholas
Biweekly administration of low-dose docetaxel in hormone-resistant prostate cancer: pilot study of an effective subtoxic therapy.
Clinical prostate cancer 2003;2(1):46-9.
2003: Bamias Aristotle T; Bai Maria C; Agnantis Niki J; Michael Michael C; Alamanos Yiannis P; Stefanaki Stella V; Razi Evagelia D; Skarlos Dimosthenis V; Kappas Angelos M; Pavlidis Nicholas A
Prognostic significance of the deleted in colorectal cancer gene protein expression in high-risk resected gastric carcinoma.
Cancer investigation 2003;21(3):333-40.
2003: Ioannidis J P A; Pavlidis N
Levels of absolute survival benefit for systemic therapies of advanced cancer. a call for standards.
European journal of cancer (Oxford, England : 1990) 2003;39(9):1194-8.
2003: Ioachim E; Tsanou E; Briasoulis E; Batsis Ch; Karavasilis V; Charchanti A; Pavlidis N; Agnantis N J
Clinicopathological study of the expression of hsp27, pS2, cathepsin D and metallothionein in primary invasive breast cancer.
Breast (Edinburgh, Scotland) 2003;12(2):111-9.
2003: Liberopoulos Evagelos; Tolis Christos; Bai Mary; Efremidis Stavros; Pavlidis Nikolaos; Elisaf Moses
Successful treatment of human immunodeficiency virus-related Castleman's disease: a case report and literature review.
Oncology 2003;65(2):182-6.
2003: Pavlidis N
Cancer of unknown primary: biological and clinical characteristics.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14 Suppl 3():iii11-8.
2003: Economopoulos Theofanis; Fountzilas George; Pavlidis Nicholas; Kalantzis Dimitris; Papageorgiou Efstathios; Christodoulou Christos; Hamilos George; Nicolaides Costas; Dimopoulos Meletios
Rituximab in combination with CNOP chemotherapy in patients with previously untreated indolent non-Hodgkin's lymphoma.
The hematology journal : the official journal of the European Haematology Association / EHA 2003;4(2):110-5.
2003: Bamias A; Aravantinos G; Kalofonos C; Timotheadou N; Siafaka V; Vlahou I; Janinis D; Pectasides D; Pavlidis N; Fountzilas G;
Prevention of anemia in patients with solid tumors receiving platinum-based chemotherapy by recombinant human Erythropoietin (rHuEpo): a prospective, open label, randomized trial by the Hellenic Cooperative Oncology Group.
Oncology 2003;64(2):102-10.
2002: Ioachim E; Charchanti A; Briasoulis E; Karavasilis V; Tsanou H; Arvanitis D L; Agnantis N J; Pavlidis N
Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression.
European journal of cancer (Oxford, England : 1990) 2002;38(18):2362-70.
2002: Christodolou C; Pavlidis N; Samantas E; Fountzilas G; Kouvatseas G; Pagdatoglou K; Palamidas F; Nikolaidis C; Angelidou M; Kalofonos H P; Kosmidis P; Skarlos D V
Prognostic factors in Greek patients with small cell lung cancer (SCLC). A Hellenic Cooperative Oncology Group study.
Anticancer research 2002;22(6B):3749-57.
2002: Briasoulis Evangelos; Karavasilis Vasilis; Tzamakou Eleftheria; Haidou Constantina; Piperidou Christina; Pavlidis Nicholas
Pharmacodynamics of non-break weekly paclitaxel (Taxol) and pharmacokinetics of Cremophor-EL vehicle: results of a dose-escalation study.
Anti-cancer drugs 2002;13(5):481-9.
2002: Andreopoulou E; Andreopoulos D; Adamidis K; Fountzila-Kalogera A; Fountzilas G; Dimopoulos M A; Aravantinos G; Zamboglou N; Baltas D; Pavlidis N
Tumor volumetry as predictive and prognostic factor in the management of ovarian cancer.
Anticancer research 2002;22(3):1903-8.
2002: Economopoulos T; Dimopoulos M A; Mellou S; Pavlidis N; Samantas E; Nicolaides C; Tsatalas C; Papadopoulos A; Papageogriou E; Papasavvas P; Fountzilas G
Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP.
European journal of haematology 2002;68(3):135-43.
2002: Schellens J H M; Heinrich B; Lehnert M; Gore M E; Kaye S B; Dombernowsky P; Paridaens R; van Oosterom A T; Verweij J; Loos W J; Calvert H; Pavlidis N; Cortes-Funes H; Wanders J; Roelvink M; Sessa C; Selinger K; Wissel P S; Gamucci T; Hanauske A R
Population pharmacokinetic and dynamic analysis of the topoisomerase I inhibitor lurtotecan in phase II studies.
Investigational new drugs 2002;20(1):83-93.
2002: Kalofonos Haralabos P; Nicolaides Costas; Samantas Epaminondas; Mylonakis Nicolaos; Aravantinos Gerasimos; Dimopoulos Meletios A; Gennatas Constantinos; Kouvatseas Georgios; Giannoulis Eleftherios; Dervenis Christos; Basdanis Georgios; Pavlidis Nicolaos; Androulakis Ioannis; Fountzilas Georgios;
A phase III study of 5-fluorouracil versus 5-fluorouracil plus interferon alpha 2b versus 5-fluorouracil plus leucovorin in patients with advanced colorectal cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.
American journal of clinical oncology 2002;25(1):23-30.
2002: Bacoyiannis C; Dimopoulos M A; Kalofonos H P; Nicolaides C; Aravantinos G; Bafaloukos D; Samelis G; Onyenadum A; Kiamouris Ch; Skarlos D; Pavlidis N; Triantafillidis A; Kosmidis P;
Vinblastine and interferon-gamma combination with and without 13-cis retinoic acid for patients with advanced renal cell carcinoma. Results of two phase II clinical trials.
Oncology 2002;63(2):130-8.
2002: Pavlidis Nicholas A
Coexistence of pregnancy and malignancy.
The oncologist 2002;7(4):279-87.
2002: Liberopoulos Evagellos; Karabina Sonia-Athena; Tselepis Alexandros; Bairaktari Eleni; Nicolaides Costas; Pavlidis Nikolaos; Elisaf Moses
Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?
Oncology 2002;62(2):115-20.
2001: Bai M; Vlachonikolis J; Agnantis N J; Tsanou E; Dimou S; Nicolaides C; Stefanaki S; Pavlidis N; Kanavaros P;
Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2001;14(11):1105-13.
2001: Briasoulis E; Agnantis N J; Zagorianakou P; Kamina S; Gorezi M; Pavlidis N; Bai M
Near-absolute expression of the bcl-2 protein identifies a subgroup of stage II breast cancer patients with a most favorable outcome. Results of a clinicopathological study.
Journal of experimental & clinical cancer research : CR 2001;20(3):341-4.
2001: Skarlos D V; Samantas E; Briassoulis E; Panoussaki E; Pavlidis N; Kalofonos H P; Kardamakis D; Tsiakopoulos E; Kosmidis P; Tsavdaridis D; Tzitzikas J; Tsekeris P; Kouvatseas G; Zamboglou N; Fountzilas G
Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: a randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(9):1231-8.
2001: Elisaf M S; Bairaktari E T; Nicolaides C; Kakaidi B; Tzallas C S; Katsaraki A; Pavlidis N A
Effect of letrozole on the lipid profile in postmenopausal women with breast cancer.
European journal of cancer (Oxford, England : 1990) 2001;37(12):1510-3.
2001: Schellens J H; Dombernowsky P; Cassidy J; Epelbaum R; Dirix L; Cox E H; Wanders J; Calabresi F; Paridaens R; Monfardini S; Wolff J; Loos W J; Verweij J; Pavlidis N; Hanauske A R;
Population pharmacokinetics and dynamics in phase II studies of the novel bioreductive alkylating cytotoxic indoloquinone EO9.
Anti-cancer drugs 2001;12(7):583-90.
2001: Bamias A; Baltayiannis G; Kamina S; Fatouros M; Lymperopoulos E; Agnanti N; Tsianos E; Pavlidis N
Rectal metastases from lobular carcinoma of the breast: report of a case and literature review.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(5):715-8.
2001: Fountzilas G; Papadimitriou C; Dafni U; Bafaloukos D; Skarlos D; Moulopoulos L A; Razis E; Kalofonos H P; Aravantinos G; Briassoulis E; Papakostas P; Abela K; Gogas E; Kosmidis P; Pavlidis N; Dimopoulos M A
Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: a randomized study conducted by the Hellenic Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2232-9.
2001: Briasoulis E; Andreopoulou E; Tolis C F; Bairaktari E; Katsaraki A; Dimopoulos M A; Fountzilas G; Seferiadis C; Pavlidis N
G-CSF induces elevation of circulating CA 15-3 in breast carcinoma patients treated in an adjuvant setting.
Cancer 2001;91(5):909-17.
2001: Fountzilas G; Papadimitriou C; Aravantinos G; Nicolaides C; Stathopoulos G; Bafaloukos D; Kalofonos H; Ekonomopoulos T; Skarlos D; Pavlidis N; Dimopoulos A M
Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancer.
Oncology 2001;60(3):214-20.
2001: Briasoulis E; Pavlidis N
Noncardiogenic pulmonary edema: an unusual and serious complication of anticancer therapy.
The oncologist 2001;6(2):153-61.
2001: Razis E; Dimopoulos A M; Bafaloukos D; Papadimitriou C; Kalogera-Fountzila A; Kalofonos H; Briassoulis E; Samantas E; Keramopoulos A; Pavlidis N; Kosmidis P; Fountzilas G
Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancer.
Cancer investigation 2001;19(2):137-44.
2000: Briasoulis E; Judson I; Pavlidis N; Beale P; Wanders J; Groot Y; Veerman G; Schuessler M; Niebch G; Siamopoulos K; Tzamakou E; Rammou D; Wolf L; Walker R; Hanauske A
Phase I trial of 6-hour infusion of glufosfamide, a new alkylating agent with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters: a study of the European Organization for Research and Treatment of Cancer Early Clinical Studies Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(20):3535-44.
2000: Briasoulis E; Kalofonos H; Bafaloukos D; Samantas E; Fountzilas G; Xiros N; Skarlos D; Christodoulou C; Kosmidis P; Pavlidis N
Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(17):3101-7.
2000: Elisaf M S; Nakou K; Liamis G; Pavlidis N A
Tamoxifen-induced severe hypertriglyceridemia and pancreatitis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(8):1067-9.
2000: Briasoulis E; Karavasilis V; Pavlidis N
Successful rechallenge with taxanes following prophylactic ketotifen in patients who had developed severe hypersensitivity reactions.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(7):899.
2000: Nicolaides C; Dimopoulos M A; Samantas E; Bafaloukos D; Kalofonos C; Fountzilas G; Razi E; Kosmidis P; Pavlidis N
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: a phase II study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(7):873-5.
2000: Kosmidis P; Mylonakis N; Skarlos D; Samantas E; Dimopoulos M; Papadimitriou C; Kalophonos C; Pavlidis N; Nikolaidis C; Papaconstantinou C; Fountzilas G
Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(7):799-805.
2000: Gamucci T; Paridaens R; Heinrich B; Schellens J H; Pavlidis N; Verweij J; Sessa C; Kaye S; Roelvink M; Wanders J; Hanauske A
Activity and toxicity of GI147211 in breast, colorectal and non-small-cell lung cancer patients: an EORTC-ECSG phase II clinical study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(7):793-7.
2000: Aravantinos G; Dimopoulos M A; Kosmidis P; Bafaloukos D; Papadimitriou C; Kiamouris C; Pavlidis N; Sikiotis K; Papakostas P; Skarlos D V
Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistant paclitaxel-pretreated ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(5):607-12.
2000: Pectasides D; Economopoulos T; Kouvatseas G; Antoniou A; Zoumbos Z; Aravantinos G; Tsatalas C; Halikia A; Nikolaides C; Kiamouris C; Pappa E; Pavlidis N; Skarlos D; Fountzilas G; Dimopoulos M A
Anthracycline-based chemotherapy of primary non-Hodgkin's lymphoma of the testis: the hellenic cooperative oncology group experience.
Oncology 2000;58(4):286-92.
2000: Katsimbri P P; Bamias A T; Froudarakis M E; Peponis I A; Constantopoulos S H; Pavlidis N A
Endobronchial metastases secondary to solid tumors: report of eight cases and review of the literature.
Lung cancer (Amsterdam, Netherlands) 2000;28(2):163-70.
2000: Fountzilas G; Zisiadis A; Dafni U; Konstantaras C; Hatzitheoharis G; Papavramidis S; Bousoulegas A; Basdanis G; Giannoulis E; Dokmetzioglou J; Katsohis C; Nenopoulou E; Karvounis N; Briassoulis E; Aravantinos G; Kosmidis P; Skarlos D; Pavlidis N
Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvant treatment, in patients with high-risk colon cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
Oncology 2000;58(3):227-36.
2000: Katsimbri P; Bamias A; Pavlidis N
Prevention of chemotherapy-induced alopecia using an effective scalp cooling system.
European journal of cancer (Oxford, England : 1990) 2000;36(6):766-71.
2000: Kosmidis P; Mylonakis N; Dimopoulos A; Pavlidis N; Fountzilas G; Samantas E; Dimitriadis K; Kalophonos C; Tsavdaridis D; Skarlos D
Combination chemotherapy with paclitaxel plus carboplatin versus paclitaxel plus gemcitabine in inoperable non-small cell lung cancer: a phase III randomized study. Preliminary results. Hellenic Cooperative Oncology Group.
Seminars in oncology 2000;27(1 Suppl 2):3-8.
2000: Janinis J; Giannakakis T; Athanasiades A; Fountzilas G; Bafaloukos D; Kosmidis P; Nikolaides K; Pavlidis N; Skarlos D
A randomized open-label parallel-group study comparing ondansetron with ondansetron plus dexamethasone in patients with metastatic breast cancer receiving high-dose epirubicin. A Hellenic Cooperative Oncology Group study.
Tumori 2000;86(1):37-41.
2000: Briasoulis E; Froudarakis M; Milionis H J; Peponis I; Constantopoulos S; Pavlidis N
Chemotherapy-induced noncardiogenic pulmonary edema related to gemcitabine plus docetaxel combination with granulocyte colony-stimulating factor support.
Respiration; international review of thoracic diseases 2000;67(6):680-3.
2000: Pavlidis N A
Cancer and pregnancy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11 Suppl 3():247-53.
2000: Pavlidis N; Aamdal S; Awada A; Calvert H; Fumoleau P; Sorio R; Punt C; Verweij J; van Oosterom A; Morant R; Wanders J; Hanauske A R
Carzelesin phase II study in advanced breast, ovarian, colorectal, gastric, head and neck cancer, non-Hodgkin's lymphoma and malignant melanoma: a study of the EORTC early clinical studies group (ECSG).
Cancer chemotherapy and pharmacology 2000;46(2):167-71.
2000: Fountzilas G; Nicolaides C; Bafaloukos D; Kalogera-Fountzila A; Kalofonos H; Samelis G; Aravantinos G; Pavlidis N
Docetaxel and gemcitabine in anthracycline-resistant advanced breast cancer: a Hellenic Cooperative Oncology Group Phase II study.
Cancer investigation 2000;18(6):503-9.
1999: Briasoulis E; Karavasilis V; Anastasopoulos D; Tzamakou E; Fountzilas G; Rammou D; Kostadima V; Pavlidis N
Weekly docetaxel in minimally pretreated cancer patients: a dose-escalation study focused on feasibility and cumulative toxicity of long-term administration.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(6):701-6.
1999: Fountzilas G; Zisiadis A; Dafni U; Konstantaras C; Hatzitheoharis G; Liaros A; Athanassiou E; Dombros N; Dervenis C; Basdanis G; Gamvros O; Souparis A; Briasoulis E; Samantas E; Kappas A; Kosmidis P; Skarlos D; Pavlidis N
Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(6):671-6.
1999: Fountzilas G; Stathopoulos G; Nicolaides C; Kalogera-Fountzila A; Kalofonos H; Nikolaou A; Bacoyiannis C; Samantas E; Papadimitriou C; Kosmidis P; Daniilidis J; Pavlidis N
Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(4):475-8.
1999: Samantas E; Skarlos D V; Pectasides D; Nicolaides P; Kalofonos H; Mylonakis N; Vardoulakis T h; Kosmidis P; Pavlidis N; Fountzilas G
Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1999;23(2):159-68.
1999: Skarlos D V; Samantas E; Pectasides D; Pavlidis N; Kalofonos C; Klouvas G; Panoussaki E; Tsiakopoulos E; Poulakis N; Fountzilas G
Weekly alternating non-cross-resistant chemotherapy for small cell lung cancer with a good prognosis: a study of the Hellenic Cooperative Oncology Group.
American journal of clinical oncology 1999;22(1):87-93.
1998: Stefanou D G; Nonni A V; Agnantis N J; Athanassiadou S E; Briassoulis E; Pavlidis N
p53/MDM-2 immunohistochemical expression correlated with proliferative activity in different subtypes of human sarcomas: a ten-year follow-up study.
Anticancer research 1998;18(6B):4673-81.
1998: Economopoulos T; Fountzilas G; Kostourou A; Daniilidis J; Pavlidis N; Andreopoulou H; Nicolaou A; Papageorgiou E; Mellou S; Dervenoulas J; Stathakis N
Primary extranodal non Hodgkin's lymphoma of the head and neck in adults: a clinicopathological comparison between tonsillar and non tonsillar lymphomas. (Hellenic co-Operative Oncology Group).
Anticancer research 1998;18(6B):4655-60.
1998: Fountzilas G; Nicolaides C; Aravantinos G; Skarlos D; Kosmidis P; Papakostas P; Stathopoulos G P; Kontostolis E; Bafaloukos D; Pavlidis N
Dose-dense adjuvant chemotherapy with epirubicin monotherapy in patients with operable breast cancer and >/=10 positive axillary lymph nodes. A feasibility study.
Oncology 1998;55(6):508-12.
1998: Fountzilas G; Dimopoulos A M; Papadimitriou C; Kalogera-Fountzila A; Aravantinos G; Bafaloukos D; Athanassiades A; Nicolaides C; Keramopoulos A; Pavlidis N; Kosmidis P; Skarlos D
First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): a phase II study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(9):1031-4.
1998: Briasoulis E; Tsavaris N; Fountzilas G; Athanasiadis A; Kosmidis P; Bafaloukos D; Skarlos D; Samantas E; Pavlidis N
Combination regimen with carboplatin, epirubicin and etoposide in metastatic carcinomas of unknown primary site: A Hellenic Co-Operative Oncology Group Phase II Study.
Oncology 1998;55(5):426-30.
1998: Nicolaides C; Fountzilas G; Zoumbos N; Skarlos D; Kosmidis P; Pectasides D; Karabelis A; Giannakakis T; Symeonidis A; Papadopoulos A; Antoniou F; Pavlidis N
Diffuse large cell lymphomas: identification of prognostic factors and validation of the International Non-Hodgkin's Lymphoma Prognostic Index. A Hellenic Cooperative Oncology Group Study.
Oncology 1998;55(5):405-15.
1998: Dimopoulos M A; Papadopoulou M; Andreopoulou E; Papadimitriou C; Pavlidis N; Aravantinos G; Aspropotamitis A; Anagnostopoulos A; Fountzilas G; Michalas S; Pectacides D
Favorable outcome of ovarian germ cell malignancies treated with cisplatin or carboplatin-based chemotherapy: a Hellenic Cooperative Oncology Group study.
Gynecologic oncology 1998;70(1):70-4.
1998: Nicolaides C; Giannakakis T; Skarlos D; Athanassiadis A; Fountzilas G; Damigos D; Pavlidis N
Tropisetron in the prevention of acute nausea and vomiting in patients treated with high dose epirubicin.
Journal of experimental & clinical cancer research : CR 1998;17(1):71-5.
1998: Kalogera-Fountzila A; Kosmidis P; Bacoyiannis C; Nicolaou A; Samantas E; Briassoulis E; Pavlidis N; Skarlos D; Daniilidis J; Fountzilas G
Prognostic factors influencing complete response to treatment and survival of patients with nasopharyngeal cancer.
Anticancer research 1998;18(1B):587-93.
1998: Bafaloukos D; Fountzilas G; Skarlos D; Pavlidis N; Bakoyiannis C; Karvounis N; Kosmidis P
Subcutaneous low doses of interleukin-2 and recombinant interferon alpha with carboplatin and vinblastine in patients with advanced melanoma.
Oncology 1998;55(1):48-52.
1997: Fountzilas G; Athanassiades A; Giannakakis T; Briasoulis E; Bafaloukos D; Kalogera-Fountzila A; Onienaoum A; Kalofonos H; Pectasides D; Andreopoulou E; Bamia C; Kosmidis P; Pavlidis N; Skarlos D
A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(12):1213-20.
1997: Fountzilas G; Athanassiades A; Kalogera-Fountzila A; Samantas E; Bacoyiannis C; Briassoulis E; Pavlidis N; Kosmidis P; Skarlos D
Paclitaxel in combination with carboplatin or gemcitabine for the treatment of advanced head and neck cancer.
Seminars in oncology 1997;24(6 Suppl 19):S19-28-S19-32.
1997: Fountzilas G; Vasilaros S; Koukouras D; Malamos N; Pectasides D; Adamou A; Nenopoulou E; Kiriakou K; Zouvani I; Katsohis K; Kappas A; Skopa C; Semoglou C; Fahantidis E; Konstantaras C; Vasilaki E; Economopoulos T; Bacoyiannis H; Bafaloukos D; Razi E; Polichronis A; Androulakis G; Papaioannou T; Pavlidis N; Kosmidis P
Prognostic variables in greek patients with stage II breast cancer: a Hellenic Cooperative Oncology Group study.
Anticancer research 1997;17(6D):4681-9.
1997: Fountzilas G; Athanassiadis A; Kalogera-Fountzila A; Aravantinos G; Bafaloukos D; Briasoulis E; Dombros N; Ioannidis I; Pavlidis N; Kosmidis P; Skarlos D
Paclitaxel by 3-h infusion and carboplatin in anthracycline-resistant advanced breast cancer. A phase II study conducted by the Hellenic Cooperative Oncology Group.
European journal of cancer (Oxford, England : 1990) 1997;33(11):1893-5.
1997: Skarlos D V; Aravantinos G; Kosmidis P; Athanassiadis A; Stathopoulos G P; Pavlidis N; Bafaloukos D; Karphathios S; Papakostas P; Bamia C; Fountzilas G
Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.
Seminars in oncology 1997;24(5 Suppl 15):S15-57-S15-61.
1997: Tsavaris N; Primikirios N; Mylonakis N; Varouchakis G; Dosios T; Pavlidis N; Skarlos D; Tasopoulos T; Dritsas J; Kosmidis P
Combination chemotherapy with cisplatin and/or doxorubicin in malignant mesothelioma. A retrospective study [corrected from prospective].
Anticancer research 1997;17(5B):3799-802.
1997: Briasoulis E; Karavasilis V; Pavlidis N
Megestrol activity in recurrent adult type granulosa cell tumour of the ovary.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(8):811-2.
1997: Kosmidis P; Mylonakis N; Fountzilas G; Samantas E; Athanassiadis A; Pavlidis N; Skarlos D
Paclitaxel (175 mg/m2) plus carboplatin versus paclitaxel (225 mg/m2) plus carboplatin in non-small cell lung cancer: a randomized study.
Seminars in oncology 1997;24(4 Suppl 12):S12-30-S12-33.
1997: Kosmidis P A; Mylonakis N; Fountzilas G; Samantas E; Athanasiadis A; Andreopoulou E; Pavlidis N; Skarlos D
Paclitaxel and carboplatin in inoperable non-small-cell lung cancer: a phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(7):697-9.
1997: Fountzilas G; Skarlos D; Athanassiades A; Kalogera-Fountzila A; Samantas E; Bacoyiannis C; Nicolaou A; Dombros N; Briasoulis E; Dinopoulou M; Stathopoulos G; Pavlidis N; Kosmidis P; Daniilidis J
Paclitaxel by three-hour infusion and carboplatin in advanced carcinoma of nasopharynx and other sites of the head and neck. A phase II study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(5):451-5.
1997: Nicolaides C; Klouvas G; Fountzilas G; Athanassiadis A; Skarlos D; Samantas E; Kosmidis P; Mylonakis N; Pavlidis N
Intensified carboplatin regimen with GM-CSF support in non-small cell lung cancer (NSCLC). A Hellenic Co-operative Oncology Group Study (HeCOG).
Journal of experimental & clinical cancer research : CR 1997;16(1):91-4.
1996: Dirix L Y; Tonnesen F; Cassidy J; Epelbaum R; ten Bokkel Huinink W W; Pavlidis N; Sorio R; Gamucci T; Wolff I; Te Velde A; Lan J; Verweij J
EO9 phase II study in advanced breast, gastric, pancreatic and colorectal carcinoma by the EORTC Early Clinical Studies Group.
European journal of cancer (Oxford, England : 1990) 1996;32A(11):2019-22.
1996: Kosmidis P A; Tsavaris N; Skarlos D; Theocharis D; Samantas E; Pavlidis N; Briassoulis E; Fountzilas G
Fluorouracil and leucovorin with or without interferon alfa-2b in advanced colorectal cancer: analysis of a prospective randomized phase III trial. Hellenic Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(10):2682-7.
1996: Pectasides D; Pavlidis N; Gogou L; Antoniou F; Nicolaides C; Tsikalakis D
Clinical value of CA 15-3, mucin-like carcinoma-associated antigen, tumor polypeptide antigen, and carcinoembryonic antigen in monitoring early breast cancer patients.
American journal of clinical oncology 1996;19(5):459-64.
1996: Elisaf M; Bairaktari E; Nicolaides C; Fountzilas G; Tzallas C; Siamopoulos K; Tsolas O; Pavlidis N
The beneficial effect of tamoxifen on serum lipoprotein-A levels: an additional anti-atherogenic property.
Anticancer research 1996;16(5A):2725-8.
1996: Pavlidis N; Hanauske A R; Gamucci T; Smyth J; Lehnert M; te Velde A; Lan J; Verweij J
A randomized phase II study with two schedules of the novel indoloquinone EO9 in non-small-cell lung cancer: a study of the EORTC Early Clinical Studies Group (ECSG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(5):529-31.
1996: Kosmidis P; Mylonakis N; Fountzilas G; Pavlidis N; Samantas E; Karabelis A; Kattis K; Skarlos D
A prospective randomized phase III study in non-small-cell lung cancer comparing cisplatin, ifosfamide, vinblastine (VIP) versus cisplatin, ifosfamide and etoposide (VIP-16). Hellenic Co-Operative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(5):517-20.
1996: Bafaloukos D; Pavlidis N; Fountzilas G; Skarlos D; Klouvas G; Makrantonakis P; Giannakakis T; Tsavaris N; Kosmidis P
Recombinant interferon ALFA-2A in combination with carboplatin, vinblastine, and bleomycin in the treatment of advanced malignant melanoma.
American journal of clinical oncology 1996;19(3):296-300.
1996: Fountzilas G; Gossios K; Zisiadis A; Svarna E; Skarlos D; Pavlidis N
Prognostic variable in patients with advanced colorectal cancer treated with fluorouracil and leucovorin-based chemotherapy.
Medical and pediatric oncology 1996;26(5):305-17.
1996: Skarlos D V; Aravantinos G; Kosmidis P; Pavlidis N; Gennatas K; Beer M; Mylonakis N; Makrantonakis P; Klouvas G; Karpathios S; Linardou H; Konstantaras C; Fountzilas G
Carboplatin alone compared with its combination with epirubicin and cyclophosphamide in untreated advanced epithelial ovarian cancer: a Hellenic co-operative oncology group study.
European journal of cancer (Oxford, England : 1990) 1996;32A(3):421-8.
1996: Pavlidis N; Nicolaides C; Athanassiadis A; Beriatou K; Skarlos D; Giannakakis T; Kosmidis P; Karvounis N; Fountzilas G
Phase II study of 5-fluorouracil and interferon-gamma in patients with metastatic colorectal cancer. A Hellenic Cooperative Oncology Group Study.
Oncology 1996;53(2):159-62.
1996: Fountzilas G; Polichronis A; Katsohis K; Gennatas K; Toussis D; Skarlos D; Kosmidis P; Vassilaros S; Semoglou C; Giannakakis T; Fahantidis E; Klouvas G; Tsavaris N; Konstantaras C; Makrantonakis P; Kolotas C; Zamboglou N; Tsiliakos S; Hainoglou D; Mylonakis N; Pavlidis N
Cyclophosphamide, mitoxantrone, fluorouracil versus conventional CMF as adjuvant treatment in node-positive breast cancer patients. A Hellenic Cooperative Oncology Group Study.
Oncology 1996;53(2):137-46.
1996: Pavlidis N; Nicolaides C; Bairaktari E; Kalef-Ezra J; Athanassiadis A; Seferiadis C; Fountzilas G
Soluble interleukin-2 receptors in patients with advanced colorectal carcinoma.
The International journal of biological markers 1996;11(1):6-11.
1996: Kalef-Ezra J A; Pavlidis N; Klouvas G; Karantanas A; Hatzikonstantinou I; Glaros D
Elemental composition of bone minerals in women with breast cancer treated with adjuvant tamoxifen.
Breast cancer research and treatment 1996;37(2):161-8.
1995: Pavlidis N; Briassoulis E; Bai M; Fountzilas G; Agnantis N
Overexpression of C-myc, Ras and C-erbB-2 oncoproteins in carcinoma of unknown primary origin.
Anticancer research 1995;15(6B):2563-7.
1995: Pavlidis N A; Bairaktari E; Kalef-Ezra J; Nicolaides C; Seferiadis C; Fountzilas G
Serum soluble interleukin-2 receptors in epithelial ovarian cancer patients.
The International journal of biological markers 1995;10(2):75-80.
1995: Pavlidis N A; Klouvas G; Tsokos M; Bai M; Moutsopoulos H M
Cutaneous lymphocytic vasculopathy in lymphoproliferative disorders--a paraneoplastic lymphocytic vasculitis of the skin.
Leukemia & lymphoma 1995;16(5-6):477-82.
1995: Fountzilas G; Skarlos D; Katsohis C; Pavlidis N; Giannakakis T; Bafaloukos D; Fahantidis E; Klouvas G; Beer M; Kosmidis P
High-dose epirubicin and r-met-hu G-CSF (filgrastim) in the treatment of patients with advanced breast cancer: A Hellenic Cooperative Oncology Group study.
Medical and pediatric oncology 1995;24(1):23-8.
1994: Pavlidis N; Nicolaides C; Klouvas G; Briassoulis E
Is the combination of 5-fluorouracil and folinic acid effective in advanced gastric carcinoma? Results of a pilot study and review of the literature.
Journal of chemotherapy (Florence, Italy) 1994;6(6):417-22.
1994: Kiriakogiani-Psaropoulou P; Malamou-Mitsi V; Martinopoulou U; Legaki S; Tamvakis N; Vrettou E; Fountzilas G; Skarlos D; Kosmidis P; Pavlidis N
The value of neuroendocrine markers in non-small cell lung cancer: a comparative immunohistopathologic study.
Lung cancer (Amsterdam, Netherlands) 1994;11(5-6):353-64.
1994: Tsavaris N; Mylonakis N; Karvounis N; Bacoyiannis C; Briasoulis E; Skarlos D; Pavlidis N; Stamatelos G; Kosmidis P
Combination chemotherapy with cisplatin-vinblastine in malignant mesothelioma.
Lung cancer (Amsterdam, Netherlands) 1994;11(3-4):299-303.
1994: Kosmidis P A; Samantas E; Fountzilas G; Pavlidis N; Apostolopoulou F; Skarlos D
Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase III study. Hellenic Cooperative Oncology Group for Lung Cancer Trials.
Seminars in oncology 1994;21(3 Suppl 6):23-30.
1994: Economopoulos T; Stathakis N; Alexopoulos C; Pavlidis N; Constantinidou M; Briassoulis E; Papageorgiou E; Dervenoulas J; Pappa V; Vaslamatzis M
Second malignancies following treatment for Hodgkin's disease: a Greek experience.
Haematologica 1994;79(3):273-6.
1994: Pavlidis N A; Elisaf M; Bai M; Tolis C; Papadimitriou C
Primary lymphoma of the pericardium: report on a "cured" case and review of the literature.
Medical and pediatric oncology 1994;22(4):287-91.
1994: Fountzilas G; Skarlos D; Giannakakis T; Athanasiades A; Bafaloukos D; Kalogera-Fountzila A; Bamia C; Pavlidis N; Kosmidis P
Intensive chemotherapy with high-dose epirubicin every 2 weeks and prophylactic administration of filgrastim in advanced breast cancer.
European journal of cancer (Oxford, England : 1990) 1994;30A(7):965-9.
1994: Pavlidis N; Kalef-Ezra J; Briassoulis E; Skarlos D; Kosmidis P; Saferiadis K; Bairaktari E; Bafaloukos D; Maravegias A; Theoharis D
Evaluation of six tumor markers in patients with carcinoma of unknown primary.
Medical and pediatric oncology 1994;22(3):162-7.
1993: Pavlidis N A; Klouvas G; Nicolaides C; Karantanas A; Beer M; Fountzilas G
A phase II trial of carboplatin and vindesine in patients with non-small cell lung cancer. A Hellenic Cooperative Oncology Group study.
Lung cancer (Amsterdam, Netherlands) 1993;10(1-2):85-9.
1993: Stavropoulos N E; Ioackim-Velogianni E; Sidoni K; Stefanou D; Klouvas G; Pavlidis N
Endometrioid carcinoma of the prostate. The diagnostic value of Leu7 and prostatic specific antigen.
British journal of urology 1993;71(3):309-12.
1993: Skarlos D V; Fountzilas G; Pavlidis N; Beer M; Makrantonakis P; Aravantinos G; Pantelakos P; Tsavaris N; Karpasitis N; Kosmidis P
Megestrol acetate in cancer patients with anorexia and weight loss. A Hellenic Co-operative Oncology Group (HeCOG) study.
Acta oncologica (Stockholm, Sweden) 1993;32(1):37-41.
1992: Pavlidis N; Kosmidis P; Skarlos D; Briassoulis E; Beer M; Theoharis D; Bafaloukos D; Maraveyas A; Fountzilas G
Subsets of tumors responsive to cisplatin or carboplatin combinations in patients with carcinoma of unknown primary site. A Hellenic Cooperative Oncology Group Study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(8):631-4.
1992: Pavlidis N A; Petris C; Briassoulis E; Klouvas G; Psilas C; Rempapis J; Petroutsos G
Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patients.
Cancer 1992;69(12):2961-4.
1992: Kalef-Ezra J; Glaros D; Klouvas G; Hatzikonstantinou J; Karantanas A; Siamopoulos K C; Pavlidis N
New evidence that tamoxifen does not induce osteoporosis: a nuclear activation analysis and absorptiometry study.
The British journal of radiology 1992;65(773):417-20.
1992: Pavlidis N A; Briassoulis E; Klouvas G; Bai M
Is interferon-a an active agent in Castleman's disease?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(1):85-6.
1992: Pavlidis N A; Manoussakis M N; Germanidis G S; Moutsopoulos H M
Serum-soluble interleukin-2 receptors in B-cell lymphoproliferative malignancies.
Medical and pediatric oncology 1992;20(1):26-31.
1992: Pavlidis N A; Drosos A A; Papadimitriou C; Talal N; Moutsopoulos H M
Lymphoma in Sjogren's syndrome.
Medical and pediatric oncology 1992;20(4):279-83.
1992: Economopoulos T; Asprou N; Stathakis N; Fountzilas G; Pavlidis N; Papaspyrou S; Dervenoulas J; Belia M; Papageorgiou E; Theoharis D
Primary extranodal non-Hodgkin's lymphoma of the head and neck.
Oncology 1992;49(6):484-8.
1991: Pavlidis N A; Klouvas G; Kyparissiadis P; Sourla A; Papademetriou C
Extraskeletal Ewing's sarcoma. Presentation of two cases and review of the literature.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1991;17(3):308-12.
1991: Fountzilas G; Skarlos D; Pavlidis N A; Makrantonakis P; Tsavaris N; Kalogera-Fountzila A; Giannakakis T; Beer M; Kosmidis P
High-dose epirubicin as a single agent in the treatment of patients with advanced breast cancer. A Hellenic Co-operative Oncology Group study.
Tumori 1991;77(3):232-6.
1990: Katsikis P D; Pavlidis N A; Papadopoulos N M; Bai M; Moutsopoulos H M
Monoclonal immunoglobulins and autoantibodies in lymphoid malignancies.
Anticancer research 1990;10(6):1719-24.
1990: Pavlidis N A; Sourla A D; Nikolaou N G; Tolis C F; Mitsi V D
Neglected cases of papillary and follicular thyroid carcinoma. Occurrence of subcutaneous scalp metastases.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1990;16(2):175-9.
1990: Pavlidis N A; Skopouli F N; Bai M C; Bourantas C L
A successfully treated case of multicentric angiofollicular hyperplasia with oral chemotherapy (Castleman's disease).
Medical and pediatric oncology 1990;18(4):333-5.
1987: Constantopoulos S H; Malamou-Mitsi V D; Goudevenos J A; Papathanasiou M P; Pavlidis N A; Papadimitriou C S
High incidence of malignant pleural mesothelioma in neighbouring villages of Northwestern Greece.
Respiration; international review of thoracic diseases 1987;51(4):266-71.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Nicholas Pavlidis

Research Profile (preview)

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Geographic Areas

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Nicholas Pavlidis (preview)

All Publications